| P2093 | author name string | Peter Hofmann | |
| P2860 | cites work | Case-finding instruments for depression. Two questions are as good as many | Q24550661 |
| | Quality of life and metabolic status in mildly depressed women with type 2 diabetes treated with paroxetine: A single-blind randomised placebo controlled trial | Q24805205 |
| | Depression and Diabetes | Q29305728 |
| | The sensitivity and specificity of the Major Depression Inventory, using the Present State Examination as the index of diagnostic validity. | Q33954931 |
| | SNRIs: their pharmacology, clinical efficacy, and tolerability in comparison with other classes of antidepressants | Q33989845 |
| | A review of the relationship between depression and diabetes in adults: is there a link? | Q34056062 |
| | The comorbidity of diabetes mellitus and depression | Q34866766 |
| | Safety and efficacy of s-citalopram in patients with co-morbid major depression and diabetes mellitus. | Q51476337 |
| | Sertraline for prevention of depression recurrence in diabetes mellitus: a randomized, double-blind, placebo-controlled trial. | Q51807493 |
| | Assessment of depression: the depression inventory | Q68787796 |
| | Fluoxetine for depression in diabetes: a randomized double-blind placebo-controlled trial | Q73840616 |
| | Association of depression and diabetes complications: a meta-analysis | Q74311132 |
| | Relationship of obesity to depression: a family-based study | Q79782850 |
| | Factors influencing glycemic control in type 2 diabetes during acute- and maintenance-phase treatment of major depressive disorder with bupropion | Q79842848 |
| | The effects of depression on diabetes knowledge, diabetes self-management, and perceived control in indigent patients with type 2 diabetes | Q81259874 |
| | Depression and all-cause and coronary heart disease mortality among adults with and without diabetes | Q81790795 |
| | Diagnosis and classification of diabetes mellitus | Q82064791 |
| | Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis | Q82747467 |
| | The prevalence of co-morbid depression in adults with Type 2 diabetes: a systematic review and meta-analysis | Q36630078 |
| | Insulin-associated weight gain in diabetes--causes, effects and coping strategies | Q36966075 |
| | Depression and diabetes treatment nonadherence: a meta-analysis | Q36975756 |
| | Obesity and weight gain in relation to depression: findings from the Stirling County Study. | Q37130605 |
| | Diabetes mellitus and co-morbid depression: treatment with milnacipran results in significant improvement of both diseases (results from the Austrian MDDM study group) | Q37224588 |
| | Long-term effects on medical costs of improving depression outcomes in patients with depression and diabetes | Q37260014 |
| | Depression in patients with diabetes: does it impact clinical goals? | Q37261105 |
| | Comparison of effects of dual transporter inhibitors on monoamine transporters and extracellular levels in rats | Q44628384 |
| | Is obesity associated with major depression? Results from the Third National Health and Nutrition Examination Survey | Q44677815 |
| | Milnacipran: a comparative analysis of human monoamine uptake and transporter binding affinity | Q44742917 |
| | Obesity among outpatients with major depressive disorder. | Q45054146 |
| | In vitro inhibition and induction of human liver cytochrome p450 enzymes by milnacipran. | Q45927503 |
| | [Diabetes and depression] | Q46446517 |
| | Comparison of fluoxetine and paroxetine in type II diabetes mellitus patients | Q46451782 |
| | Monoamine transporter gene expression in the central nervous system in diabetes mellitus. | Q48701887 |
| P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | Suppl I | |
| P921 | main subject | metformin | Q19484 |
| P304 | page(s) | 9-15 | |
| P577 | publication date | 2010-09-07 | |
| P1433 | published in | Neuropsychiatric Disease and Treatment | Q15716332 |
| P1476 | title | Treatment of patients with comorbid depression and diabetes with metformin and milnacipran | |
| P478 | volume | 6 | |